Pacira BioSciences, Inc.

8-K Entered a material agreement; Regulation FD disclosure Jun 30, 2026 8-K Director or officer change; Shareholder vote results; Other events Jun 11, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change; Regulation FD disclosure Jan 28, 2026 8-K Results of operations (earnings release) Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Exit or disposal costs; Regulation FD disclosure Jul 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Jul 7, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Other events Apr 22, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 7, 2025 8-K Amended charter or bylaws Mar 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Director or officer change; Regulation FD disclosure Jan 30, 2025 8-K Director or officer change; Regulation FD disclosure Jan 21, 2025 8-K Results of operations (earnings release) Jan 10, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Director or officer change Nov 6, 2024 8-K Director or officer change; Regulation FD disclosure Oct 21, 2024 8-K Director or officer change Sep 27, 2024 8-K Other events Sep 9, 2024 8-K Other events Aug 9, 2024 10-Q Quarter ended 2024-06-30 Jul 30, 2024 8-K Results of operations (earnings release) Jul 30, 2024 8-K Director or officer change; Shareholder vote results Jun 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 14, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events May 8, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release); Other events May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 29, 2024